QUOSA Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • QUOSA's estimated annual revenue is currently $870k per year.(i)
  • QUOSA's estimated revenue per employee is $87,000

Employee Data

  • QUOSA has 10 Employees.(i)
  • QUOSA grew their employee count by -17% last year.

QUOSA's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$75.6M4175%N/AN/A
#2
$38.6M24226%N/AN/A
#3
$277.8M1340-1%$38MN/A
#4
$29M186-35%$78.9MN/A
#5
$763.6M12414%$1.8MN/A
#6
$11.9M82-44%$19.5MN/A
#7
$64.9M358-8%N/AN/A
#8
$64.5M350-46%$130MN/A
#9
$26M16336%N/AN/A
#10
$94.5M51322%$187MN/A
Add Company

What Is QUOSA?

QUOSA, part of Elsevier Life Science Solutions, provides software solutions that support scientific literature management workflows – for full-text articles, conference abstracts and patents. QUOSA also offers integration with your document delivery process for seamless, automated access to full-text articles for your entire organization – from your subscriptions, from open-access journals, and from document delivery (while avoiding duplicate ordering). Professionals at leading pharmaceutical, biotechnology, and medical device companies, as well as academic and governmental research institutions, use our solutions to increase efficiency and effectiveness. QUOSA products and services are designed specifically for the literature management requirements of pharmaceutical and life-science firms, including Medical Affairs, R & D, Safety & Regulatory, Marketing and Business Development, Legal & Intellectual Property and Knowledge Management functions. As a complete end-to-end solution, it saves time and cost in literature monitoring and management.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$870k

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M1011%N/A
#2
N/A10-52%N/A
#3
$1.6M10-17%N/A
#4
$1.7M100%N/A
#5
$1.6M10-9%N/A